US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
ATE420628T1
(en)
|
1993-07-19 |
2009-01-15 |
Angiotech Pharm Inc |
ANTI-ANGIogenic AGENTS AND METHODS OF USE THEREOF
|
EP0914116B1
(en)
*
|
1996-05-22 |
2000-10-11 |
Protarga Inc. |
Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
WO1998013359A1
(en)
*
|
1996-09-24 |
1998-04-02 |
Marigen S.A. |
Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
US6649632B2
(en)
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
EP2014307A3
(en)
|
2001-03-13 |
2010-12-08 |
Angiotech International Ag |
Micellar drug delivery vehicles and uses thereof
|
CA2444529C
(en)
|
2001-04-20 |
2010-11-23 |
The University Of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
CA2354471A1
(en)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
C10 ester substituted taxanes
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
DE60331367D1
(en)
|
2002-12-30 |
2010-04-01 |
Angiotech Int Ag |
ACTIVE COMPOSITION OF FAST GELING POLYMERIC COMPOSITION
|
EP1633317A4
(en)
|
2003-05-16 |
2008-08-20 |
Intermune Inc |
Synthetic chemokine receptor ligands and methods of use thereof
|
SV2006002010A
(en)
|
2004-02-13 |
2006-08-23 |
Univ Florida State Res Found |
REPLACED TAXANS WITH CYCLOPENTILO ESTERS IN C10
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US8691780B2
(en)
|
2005-02-17 |
2014-04-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
AU2007228984B2
(en)
|
2006-03-22 |
2012-05-03 |
Syncore Biotechnology Co., Ltd |
Treatment of triple receptor negative breast cancer
|
EP2043704B2
(en)
|
2006-06-30 |
2017-04-19 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
EP2276755A4
(en)
|
2008-03-31 |
2011-05-04 |
Univ Florida State Res Found |
C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
ES2530462T3
(en)
|
2008-05-22 |
2015-03-03 |
Galera Therapeutics Llc |
Combination antitumor therapy
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
KR102165464B1
(en)
|
2012-07-19 |
2020-10-14 |
레드우드 바이오사이언스 인코포레이티드 |
Antibody specific for cd22 and methods of use thereof
|
CN104884056A
(en)
|
2012-11-12 |
2015-09-02 |
雷德伍德生物科技股份有限公司 |
Compounds and methods for producing a conjugate
|
DK3300745T3
(en)
|
2013-02-15 |
2019-11-04 |
Univ California |
CHEMICAL ANTIGEN RECEPTOR AND METHODS FOR USING IT
|
JP6410790B2
(en)
|
2013-03-14 |
2018-10-24 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Mitochondrial aldehyde dehydrogenase-2 modulator and method of use thereof
|
US9493413B2
(en)
|
2013-11-27 |
2016-11-15 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
US9879036B2
(en)
|
2014-02-19 |
2018-01-30 |
Aviv Therapeutics, Inc. |
Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof
|
KR20180058759A
(en)
|
2015-09-25 |
2018-06-01 |
제트와이 테라퓨틱스 인코포레이티드 |
Pharmaceutical preparations based on microparticles comprising a polysaccharide-vitamin conjugate
|
WO2017083637A1
(en)
|
2015-11-12 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
TWI760319B
(en)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
Treatment of breast cancer
|
WO2017189432A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
KR20230162139A
(en)
|
2016-06-01 |
2023-11-28 |
세르비에 아이피 유케이 리미티드 |
Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
|
TW201825087A
(en)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
Treatment of pancreatic cancer
|
AU2018211081A1
(en)
|
2017-01-18 |
2019-07-18 |
Bioatla, Inc. |
Chimeric antigen receptors against Axl or Ror2 and methods of use thereof
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
BR112020015520A2
(en)
|
2018-01-31 |
2021-02-02 |
Galera Labs, Llc |
combination therapy for cancer with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
BR112020020930A2
(en)
|
2018-04-11 |
2021-03-02 |
Ohio State Innovation Foundation |
drug delivery composition, method for treating an eye disorder and kit
|
EP3823674A4
(en)
|
2018-07-18 |
2022-12-28 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
WO2020148612A1
(en)
|
2019-01-14 |
2020-07-23 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
JP2022520220A
(en)
|
2019-02-14 |
2022-03-29 |
イグナイト イミュノセラピー インク |
Recombinant vaccinia virus and how to use it
|
BR112021019701A2
(en)
|
2019-04-02 |
2021-12-14 |
Kenjockety Biotechnology Inc |
Multispecific antibodies to efflux pump cancer antigen and compositions, reagents, kits and methods related thereto
|
CN115380041A
(en)
|
2019-12-12 |
2022-11-22 |
伊格奈特免疫疗法公司 |
Variant oncolytic vaccinia viruses and methods of use thereof
|
WO2021155028A1
(en)
|
2020-01-29 |
2021-08-05 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
AU2021284240A1
(en)
|
2020-06-04 |
2022-12-08 |
Kenjockety Biotechnology, Inc. |
Anti-ABCG2 antibodies and uses thereof
|
CN116529267A
(en)
|
2020-06-04 |
2023-08-01 |
肯乔克蒂生物技术股份有限公司 |
ABCG2 efflux pump-cancer antigen multispecific antibodies and related compositions, reagents, kits and methods
|
BR112023000650A2
(en)
|
2020-07-14 |
2023-01-31 |
Pfizer |
RECOMBINANT VACCINIA VIRUS
|
AU2021338286A1
(en)
|
2020-09-02 |
2023-03-23 |
Kenjockety Biotechnology, Inc. |
Anti-ABCC1 antibodies and uses thereof
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
AU2022413942A1
(en)
|
2021-12-13 |
2024-05-30 |
William Robert Arathoon Living Trust |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|